ArticleFrontiers in oncology2022

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma.

Shui-Qing Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.